|Day Low/High||50.62 / 51.00|
|52 Wk Low/High||37.38 / 51.13|
Jim Cramer says these market rotations are crushing good stocks that don't deserve it.
Abbott CEO Miles White said on an earnings call the company will make one more asset sale as part of efforts to gain regulatory approval for the Abbott-Alere deal.
Abbott will report second-quarter numbers on Thursday as it completes the Alere deal. $ABT $ALR
The Triage assets are being divested in order to secure antitrust approvals for Abbott Laboratories' purchase of Alere.
What we'll be looking for from ABT, NUE, DHR, KEY, SNA, GE and SLB.
The second-quarter earnings season picks up speed.
The market surged this week as positive earnings and a mellower tone from Janet Yellen cheered bulls.
Here's what you need to know now.
A deep dive into 3 of the 10 stocks we highlighted during yesterday's members-only call.
- AGREEMENT PROMISES MAJOR LEAP FORWARD IN AUTOMATION OF DIABETES MANAGEMENT
Here's what to focus on from these stocks in July.
Jobs report and Fed minutes highlight a short week. In the portfolio, we add one name and downgrade another.
The final vote results will be filed on a Form 8-K with the Securities and Exchange Commission.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ABT, BH, CUBN, PYPL, REIS Downgrades: FRED, FSBC, TDOC Initiations: BBU, CLSD Read on to get TheStreet Quant Ratings' detailed report:
Drones to the rescue!
We held back on any big portfolio moves as the quarter ended with bank stress test results and merger news.
- REVOLUTIONARY SYSTEM ELIMINATES THE NEED FOR ROUTINE FINGER STICKS1 AND FINGER STICK CALIBRATION
Anadarko has almost 40% upside. Abbott has 20% upside.